Patrick Murray 💙🇺🇦

Brilliant to see @Independent highlighting the APHRODITE trial - and to read Tom Critchley's story as a patient on the trial. Tom, thank you so much for helping other cancer patients by contributing to clinical research 😍 independent.co.uk/news/health/pe…

We’re pleased to announce the publication of ‘Principles of reirradiation’. These principals have been produced to guide and support clinicians in contentious areas of practice that lack strong evidence. 🔗 rcr.ac.uk/our-services/a…

What a blast! The #ReCOG meeting was absolutely fantastic, thanks to amazing colleagues and so many inspiring #reirradiation discussions. Now the hard work begins to turn all the ideas and intentions into a proper international consortium 🤩 #radonc #medphys #radiobiology

1/n Our phase II trial publication is finally out describing a simple strategy of boosting the primary tumor in locally-advanced #lungcancer with 6-8 Gy x 2 shortly prior to conventional chemoradiation (CRT)❗️ #lcsm #SBRT #SABR #NSCLC #radonc @cityofhope @COH_RadOnc @COHMedOnc

1/ NEW & IMPORTANT: So we need to talk about NHS pay. NEW shocking [post DDRB] data just in 4/1/24 👇 (SPOILER: Not "fair & reasonable") We need to fix pay/retention to fix waiting lists- increasingly clear next GE will won/lost on NHS Please read whole 🧵 & share widely/RT

Excellent work on #reirradiation patterns-of-practice by @jonas_willmann and @NAndratschke, with important data to inform future research & clinical guidelines. A real pleasure to be allowed to contribute to designing and writing up this study #radonc #medphys

Come join us in Glasgow! This is going to be an amazing pre-meeting course - so many excellent speakers lined up 🤩 @elivaos @SorenBentzen @MarianneGuren @ChuckMayoPhD @jonas_willmann @NAndratschke #whereishoskin #medphys #radonc

So honoured to have been part of the PACE team for the last 12 years. I have learned so much from @nickva1 @EmmaHall71 and the whole team. Thanks to the 874 men and over 30 hospitals who partnered with us and to Accuray for funding. Abstract here astro2023.eventscribe.net/index.asp?sess…

Headline news @BBC tonight! Quite unusual to see a health article leading the news, congratulations to @nickva1 @EmmaHall71 @alison_tree @DrAndrewLoblaw and everyone involved in this practice changing research!

🧵1/ 🙏🏾🙏🏾Thank you patients, families, trial staff and investigators for participating in @TROGfightcancer 15.03 FASTRACK II! This trial recruited n=70 across 8 sites in 🇦🇺 and 🇳🇱 #ASTRO23! #radonc #kcsm #radiotherapy @ANZUPtrials @KidneyCancer

Huge congratulations to all @PLATOtrial sites across the UK - we have now recruited 463 pts to ACT5! 🌟 A brilliant multi-disciplinary team effort successfully recruiting over target in a rare cancer! Thank you so much for your support!🥳💞 @CR_UK @SU2C @LeedsCTRU @MontefioreD

The sights and colours of #CupMatch2023 🏏🇧🇲🇧🇲

So much smearing & belittling of consultants in the press, but this, from today’s @thetimes letters page, could not have put it more beautifully. Pls RT if you agree. #NHS 💙

"Radiotherapy is the most #costeffective of the three main cancer treatments." "Radiotherapy is the closest thing to a silver bullet." It would be amazing to see similar articles like this in the 🇺🇸! However, it's all about the clickbait on this side of the pond... #radonc

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ @IASLC @MDAndersonNews @TheLancet @ACKoongMDPhD @StephenVLiu

Tomorrow in Westminster Hall, @SelaineSaxby is leading a debate on accessibility of radiotherapy. Read the @commonslibrary debate pack 📙 commonslibrary.parliament.uk/research-brief… Watch from 9.30am 📺 parliamentlive.tv/Event/Index/89… On making the debate application, she said:

Supply and demand continue to be macroeconomic facts that operate in parallel to inflation and taxes. We’d love to welcome NHS docs to #Canada so we can increase our supply and meet patient demand. @CMA_Docs is working hard to make it easier for colleagues worldwide to join us!…

Not all SBRT are created equal: 1. Diff dose regimens have diff. effi/toxic. 2. For optimal immune activation, it needs ablative dose, not 8 Gy X3 2. Diff. histologies are diff. diseases, shouldn’t mix for efficacy 3. Diff. RT to diff. diseases are different Drugs. @JAMAOnc

This 15 year workforce plan is not fully funded. The £2.4bn for new training doesn't cover the increased salaries - there is a huge revenue bill the NHS will need funding as these roles come through. The plan is more aspiration than a plan of how it will be done #NHSWorkforcePlan

This is crazy. @NCRI_partners has played such a massive & crucial role in cancer research in the UK. What's going to happen to #CTRad and similar national collaborative initiatives? #radonc #clinonc #medphys